NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...

Abstract: Human and animal classification under the rubble is necessary to successfully rescue survivors post-disaster, and interference from other animals is becoming an issue in noncontact ...

Abstract: The Intelligent Animal Care and Management System Based on the Internet of Things is a comprehensive solution for monitoring and managing animals in a zoo environment. The system uses a ...